Key result
Cardiac rehabilitation at VA facilities shows no difference in 1-year mortality versus non-VA facilities.
Why the study?
Participation in VA cardiac rehabilitation programs is low, with most veterans receiving care at non-VA facilities, but limited literature exists comparing clinical outcomes between VA and non-VA programs.
Does participation in VA cardiac rehabilitation compared to non-VA cardiac rehabilitation reduce 1-year mortality and readmission in veterans hospitalized for myocardial infarction or coronary revascularization?
Cohort (n=7,320)
Yes
Does participation in VA cardiac rehabilitation compared to non-VA cardiac rehabilitation reduce 1-year mortality and readmission in veterans hospitalized for myocardial infarction or coronary revascularization?
Participation in cardiac rehabilitation at VA facilities compared with non-VA facilities was associated with similar 1-year mortality and readmission rates among veterans with ischemic heart disease.
Answers are grounded in this paper and cite their sources.
Similar 1-year outcomes with VA versus non-VA cardiac rehabilitation; leaves open whether facility-specific factors affect other veteran populations or longer-term events.
Importance: Participation in cardiac rehabilitation (CR) programs at Veterans Affairs (VA) facilities is low. Most veterans receive CR through purchased care at non-VA programs. However, limited literature exists on the comparison of outcomes between VA and non-VA CR programs. Objective: To compare 1-year mortality and 1-year readmission rates for myocardial infarction or coronary revascularization between VA vs non-VA CR participants. Design, Setting, and Participants: This cohort study included 7320 patients hospitalized for myocardial infarction or coronary revascularization at the VA between 2010 and 2014 who did not die within 30 days of discharge and who participated in 2 or more CR sessions after discharge. The study excluded individuals hospitalized for ischemic heart disease after December 2014 when the VA Choice Act changed referral criteria for non-VA care. Data analysis was performed from November 2019 to January 2020. Exposures: Participation in 2 or more CR sessions within 12 months of discharge at a VA or non-VA facility. Main Outcomes and Measures: The 1-year all-cause mortality and 1-year readmission rates for myocardial infarction or coronary revascularization from date of discharge were compared between VA vs non-VA CR participants using Cox proportional hazards models with inverse probability treatment weighting. Results: The 7320 veterans with ischemic heart disease who participated in CR programs had a mean (SD) age of 65.13 (8.17) years and were predominantly white (6005 patients [82.0%]), non-Hispanic (6642 patients [91.0%]), and male (7191 patients [98.2%]). Among these 7320 veterans, 2921 (39.9%) attended a VA facility, and 4399 (60.1%) attended a non-VA CR facility. Black and Hispanic veterans were more likely to attend CR programs at VA facilities (509 patients [17.4%] and 378 patients [12.9%], respectively), whereas white veterans were more likely to attend CR programs at non-VA facilities (3759 patients [85.5%]). After inverse probability treatment weighting, rates of 1-year mortality were 1.7% among VA CR participants vs 1.3% among non-VA CR participants (hazard ratio, 1.32; 95% CI, 0.90-1.94; P = .15). Rates of readmission for myocardial infarction or revascularization during the 12 months after discharge were 4.9% among VA CR participants vs 4.4% among non-VA CR participants (hazard ratio, 1.06; 95% CI, 0.83-1.35; P = .62). Conclusions and Relevance: These findings suggest that rates of 1-year mortality and 1-year readmission for myocardial infarction or revascularization did not differ for participants in VA vs non-VA cardiac rehabilitation programs. Eligible patients with ischemic heart disease should participate in CR programs regardless of where they are provided.
No takes yet. Share an insight, caveat, or question.
Krishnamurthi et al. (2020) conducted a cohort in Myocardial infarction or coronary revascularization (n=7,320). Cardiac rehabilitation at a VA facility vs. Cardiac rehabilitation at a non-VA facility was evaluated on 1-year all-cause mortality (HR 1.32, 95% CI 0.90-1.94, p=.15). Cardiac rehabilitation at VA facilities compared with non-VA facilities showed no significant difference in 1-year mortality (1.7% vs 1.3%; HR 1.32; 95% CI 0.90-1.94; P=0.15).
Synapse has enriched 10 related papers. Consider them for comparative context: